Stay updated with breaking news from Programs Option. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanofi collaboration for Natural Killer cell engager therapeutics expanded to B7-H3 ANKETprogram and two additional targets, with €25 million payment Encouraging preliminary TELLOMAK Phase
Monalizumab and IPH5201 developed in collaboration with AstraZeneca advanced into Phase 3 and 2 clinical trials in lung cancer, triggering $55M in milestone payments Second preclinical asset
Memorial day holiday to work. senate majority leader mitch mcconnell says they worry it could be a disaster. >> the untried and nonexistence bulk collection system under that bill would be slower and more cumbersome than the one that currently helps keep us safe. at worse, it might not work at all due to many other problems. >> reporter: senate intelligence committee chairman richard burr has offered a compromise which would include a house bill and allow two years for transition to the telecom companies. failure to extend these programs option. >> we run the risk of essentially being left fac...